Seronegativation in early treated HIV-infected infants: Frequency and potential implications on care and follow-up in a resource-limited country

Journal of Acquired Immune Deficiency Syndromes

Volumn 58, Issue 2, 2011, Pages

  Kfutwah, Anfumbom K W ^a   Tejiokem, Mathurin Cyrille ^a,b   Ateba, Francis N ^c   Ndongo, Jean Audrey ^c   Penda, Ida Calixte ^d,e   Ngoupo, Paul Alain T ^a   Tchendjou, Patrice ^a   Chewa, Gisele ^f   Boisier, Pascal ^a   Rouzioux, Christine ^g   Warszawski, Josiane ^h,i   Faye, Albert ^g,j  

^a CENTRE PASTEUR DU CAMEROUN   (Cameroon)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c Mother and Child Centre of The Chantal Biya Foundation Yaounde   (Cameroon)

^d Hopital Laquintinie   (Cameroon)

^e UNIVERSITY OF DOUALA   (Cameroon)

^f Medical Imaging Department   (Cameroon)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

ⁱ BICÊTRE HOSPITAL   (France)

^j HÔPITAL ROBERT DEBRÉ   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

CD4 LYMPHOCYTE COUNT; CHILD CARE; EARLY DIAGNOSIS; FOLLOW UP; HEALTH CARE PLANNING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFANT; LETTER; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS LOAD;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAMEROON; FEMALE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; VIRAL LOAD;

EID: 80053004732     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31822d49f0     Document Type: Letter

References (12)

1. World Health Organization.Antiretroviral therapy of HIV infection in infants and children: towards universal access: WHO recommendations for a public health approachd2010 revision. Available at: http://www.who.int/hiv/pub/ paediatric/infants2010/en/index.html. Accessed June 8, 2011.
2. Rouet F, Ekouvi DK, Chaix ML, et al. Transfer and evaluation of an automated, low-cost real-time reverse transcriptase-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting. J Clin Microbiol. 2005;43:2709-2717. (Pubitemid 40827943)
3. World Health Organization.Guidelines for use in HIV testing and counselling services in resource-constrained settings. Available at http://www.who.int/hiv/topics/vct/toolkit/components/supply/en/index3.html. Accessed June 8, 2011.
4. Quiñonez JM, Begue RE, Steele RW. HIV seronegativity in an infant with the acquired immunodeficiency syndrome. South Med J. 1998;91:879-881.
5. De Rossi A, Giaquinto C, Del Mistro A, et al. Onset of HIV-1 antibody production after highly active antiretroviral therapy in a seronegative HIV-1-infected child. AIDS. 2000;14: 1284-1286. (Pubitemid 30420678)
6. Luzuriaga K, Mcmanus M, Catalina M, et al; for the PACTG 356 Investigators. Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses. J Virol. 2000;74:6984-6991. (Pubitemid 30470681)
7. Ly TD, Martin L, Daghfal D, et al. Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection. J Clin Microbiol. 2001;39: 3122-3128. (Pubitemid 32830303)
8. Malm K, von Sydow M, Andersson S. Performance of three automated fourth-generation combined HIV antigen/antibody assays in large-scale screening of blood donors and clinical samples. Transfus Med. 2009;19: 78-88.
9. van den Berk GE, Frissen PH, Regez RM, et al. Evaluation of the rapid immunoassay determine HIV 1/2 for detection of antibodies to human immunodeficiency virus types 1 and 2. J Clin Microbiol. 2003;41:3868-3869. (Pubitemid 36994730)
10. Holguín A, Gutiérrez M, Portocarrero N, et al. Performance of OraQuick Advance Rapid HIV-1/2 Antibody Test for detection of antibodies in oral fluid and serum/plasma in HIV-1+ subjects carrying different HIV-1 subtypes and recombinant variants. J Clin Virol. 2009;45:150-152.
11. Kassutto S, Johnston MN, Rosenberg ES. Incomplete HIV type 1 antibody evolution and seroreversion in acutely infected individuals treated with early antiretroviral therapy. Clin Infect Dis. 2005;40:868-873. (Pubitemid 40365508)
12. Brown P, Merline JR, Levine D, et al. Repeatedly false-negative rapid HIV test results in a patient with undiagnosed advanced AIDS. Ann Intern Med. 2008;149:71-72. (Pubitemid 351931151)